PlainPatent
USPTO 2015–2025 USPTO PatentsView US Corporation

Perkinelmer Health Sciences, Inc.

USPTO PatentsView assignee record - 185 granted patents across 55 technology areas, active 2015–2024. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: G01N (INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES).

Explore the portfolio See the ranking
185
Total patents granted
55
CPC technology areas
19.7
Avg claims per patent
-46%
5-year filing velocity

The verdict

Perkinelmer holds 185 US patents across 55 technology areas, rank #2,134 of 50,000 tracked assignees.

#2,134
of 50,000 US assignees by volume
Top 6%
by Innovation Score (56.6/100)
19.7
avg claims per patent
-46%
filing velocity, last 5 yrs

Portfolio overview

Perkinelmer Health Sciences, Inc. has been granted 185 US utility patents between 2015 and 2024, placing Perkinelmer Health Sciences, Inc. at rank #2,134 across all assignees tracked by PlainPatent. This portfolio spans 55 distinct Cooperative Patent Classification (CPC) subclasses, averaging 19.7 claims per patent with primary concentration in G01N (INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES). As a US Corporation, Perkinelmer Health Sciences, Inc. is one of the broader-portfolio assignees in the PatentsView dataset. By volume, Perkinelmer sits between National Taiwan University Of Science And Technology (185 patents, rank #2,130) and Adtran, Inc. (184 patents, rank #2,138) - the closest US assignees by grant volume. The composite Innovation Score of 56.6/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 65 grants, compared with 120 in the 2015–2019 window, a -46% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Perkinelmer Health Sciences, Inc.'s 19.7 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 55 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Perkinelmer Health Sciences, Inc. against peers pursuing similar technology classes.

Who files at Perkinelmer's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Perkinelmer holds 185 patents at rank #2,134, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Perkinelmer

By rank, the assignees closest to #2,134 in granted patent volume.

Leaders in G01N (Investigating OR Analysing Materials BY Determining Their…)

Other assignees with the most granted patents in Perkinelmer's primary technology class.

Perkinelmer's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

57 Top 6% higher than 94% of 50,000 US assignees

0–10: 687 US assignees (1%). Below this entry. 10–20: 2,527 US assignees (5%). Below this entry. 20–30: 13,162 US assignees (26%). Below this entry. 30–40: 15,294 US assignees (31%). Below this entry. 40–50: 11,491 US assignees (23%). Below this entry. 50–60: 5,058 US assignees (10%). This entry sits in this band. 60–70: 1,537 US assignees (3%). Above this entry. 70–80: 234 US assignees (0%). Above this entry. 80–90: 10 US assignees (0%). Above this entry. 90–100: 0 US assignees (0%). Above this entry. This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

-100102030 2015201620172018201920202021202220232024 1
USPTO utility patent grants by year · 2015–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Perkinelmer Health Sciences, Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 21 11.4%
2016 28 15.1%
2017 28 15.1%
2018 18 9.7%
2019 25 13.5%
2020 22 11.9%
2021 24 13.0%
2022 13 7.0%
2023 5 2.7%
2024 1 0.5%

Which technologies does Perkinelmer Health Sciences, Inc. patent most?

Top 15 of 55 technology areas

Patent Moat Analysis

Portfolio Volume Moderate
Tech Breadth Multi-domain
Claim Depth Standard
Velocity Declining

Where it ranks

Overall rank by patents

#2,134

Across all tracked assignees

Innovation Score

56.6 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Perkinelmer Health Sciences, Inc. hold?
Perkinelmer Health Sciences, Inc. holds 185 US granted patents filed between 2015 and 2024, spanning 55 technology areas.
What is Perkinelmer Health Sciences, Inc.'s Innovation Score?
Perkinelmer Health Sciences, Inc. has an Innovation Score of 56.6 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does Perkinelmer Health Sciences, Inc. focus on?
Perkinelmer Health Sciences, Inc.'s top technology area is G01N (INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES) with 83 patents. The company has filed patents in 55 CPC subclasses total.
Is Perkinelmer Health Sciences, Inc.'s patent filing rate increasing or decreasing?
Perkinelmer Health Sciences, Inc.'s recent filing velocity is -46% compared to the prior five-year period. Filing activity has slowed relative to earlier years.
What does claim depth mean for Perkinelmer Health Sciences, Inc.'s patents?
Perkinelmer Health Sciences, Inc.'s patents average 19.7 claims each. This falls within the standard range, providing solid legal coverage.
How is the Perkinelmer Health Sciences, Inc. patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

Perkinelmer's 185 grants land it in the top 6% by Innovation Score, but volume alone doesn't tell you where the strength sits.

  • Read that count against the largest US assignees before treating it as dominance - Perkinelmer ranks #2,134 of 50,000. Top 50 holders
  • Most of this portfolio concentrates in G01N - see who else leads that technology area. G01N leaders
  • Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page
  • USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
  • Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
  • USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.